In addition to impairment of cell migration and proliferation, PEA-15 expression correlates with good prognosis in neuroblastoma and a 25% increase in patient survival time with the highest PEA-15 levels found in early stage tumours (Gawecka et al., 2012). The gene discussed is PEA15; the disease is neuroblastoma.